Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 524 of 1,261
  1. US 10172695

    Method for manufacturing dental mill blank

    KURARAY NORITAKE DENTAL INC. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  2. US 10174098

    Anti-human papillomavirus 16 E7 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  3. US 10172827

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  4. US 10172786

    Oral care composition comprising cannabinoids

    AXIM BIOTECHNOLOGIES. INC. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  5. US 10174302

    Modified L-asparaginase

    Jazz Pharmaceuticals Ireland Limited · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  6. US 10174099

    Cell

    AUTOLUS LIMITED · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  7. US 10175170

    Metal coating of rare earth nano-phosphors and uses thereof

    The Regents of the University of California · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  8. US 10174290

    Method to increase the infectivity of virus particles

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  9. US 10174018

    Protein kinase inhibitors

    Princeton Drug Discovery, Inc · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  10. US 10172841

    Inhibition of crystal growth of roflumilast

    Arcutis, Inc. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  11. US 10173998

    Antifungal compound process

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  12. US 10172840

    Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof

    VTV THERAPEUTICS LLC · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  13. US 10174077

    Method of inhibiting activity of cell surface fibroblast activation protein alpha

    The Board of Regents of the University of Oklahoma · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  14. US 10174039

    P2X3 and/or P2X2/3 compounds and methods

    Asana BioSciences, LLC · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  15. US 10172844

    Use of CDK9 inhibitors to reduce cartilage degradation

    The Regents of the University of California · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  16. US 10172849

    Compositions comprising buprenorphine

    Indivior UK Limited · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  17. US 10172834

    (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

    Theravance Biopharma R&D IP, LLC · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  18. US 10172888

    Enhanced stem cell composition

    Fate Therapeutics, Inc. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  19. US 10174041

    Methods and compositions for inhibiting the interaction of menin with MLL proteins

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  20. US 10173980

    Mixed disulfide conjugates of thienopyridine compounds and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  21. US 10172880

    Talen-based gene correction

    Regents of the University of Minnesota · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  22. US 10173985

    Aminoindazole derivatives as sodium channel inhibitors

    Almirall, S.A. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  23. US 10173987

    Hydrazide containing nuclear transport modulators and uses thereof

    Karyopharm Therapeutics Inc. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted
  24. US 10172976

    Muscle cell patches and uses therefor

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.